The private tuberculosis drug market, which has irregular practices that could be driving treatment failures and the emergence of drug-resistant tuberculosis, is now shown to be as large as the public market.
The private tuberculosis drug market, which has irregular practices that could be driving treatment failures and the emergence of drug-resistant tuberculosis, is now shown to be as large as the public market.